An officer of a judicial association who was peripherally involved in a law firm’s pro bono representation of the association ...

Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits ...

Bhavesh M. Patel, Corinna J. Dauenhauer, Mohamed Y. Rady, Joel S. Larson, Tonya R. Benjamin, Daniel J. Johnson, Richard A. Helmers Journal of Patient Safety, Vol. 3 ...

A peripherally inserted central catheter (PICC) is a small, thin, and flexible tube inserted into a vein in the upper arm and guided into the superior vena cava to deliver intravenous fluids, ...

The global peripherally inserted central catheter industry value is predicted to grow from USD 1,037.0 million in 2024 to USD 1,289.9 million in 2034. Overall demand for PICCs will likely increase at ...

Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative to ...

Peripherally inserted central catheters are important but can be difficult to place in neonates. Therefore, we compared a near-infrared device, the Vein Viewer, to determine if its use would increase ...

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297 PURPOSE: ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. An interesting pair of charts to juxtapose on a Monday morning, and a PMI day… courtesy of Societe Generale.

MONTREAL--(BUSINESS WIRE)--Inversago Pharma Inc. (“the Company” or “Inversago”), the peripheral CB1 blockade company, today announced that following the receipt of a No Objection Letter (NOL) from ...

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297 PURPOSE: ...